• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Director Jennings John Webb Iii returned 56,088 shares to the company, closing all direct ownership in the company (SEC Form 4)

    1/3/25 11:10:19 AM ET
    $IBTX
    Major Banks
    Finance
    Get the next $IBTX alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
    X
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Jennings John Webb III

    (Last) (First) (Middle)
    3737 BUFFALO SPEEDWAY
    SUITE 1100

    (Street)
    HOUSTON TX 77098

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Independent Bank Group, Inc. [ IBTX ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    01/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 01/01/2025 D 56,088 D (1) 0 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Pursuant to the Merger Agreement, each share of Independent Common Stock issued and outstanding immediately prior to the effective time of the Merger was converted into the right to receive 0.60 shares of common stock, par value $2.50 per share, of SouthState (SouthState Common Stock). Shares reported include restricted stock awards. Pursuant to the Merger Agreement, each outstanding restricted stock award was fully vested, cancelled and converted into the right to receive SouthState Common Stock equal to the product (rounded to the nearest whole number) of (i) the number of Independent Common Stock subject to such restricted stock award immediately prior to the effective time of the Merger multiplied by (ii) 0.60. On December 31, 2024 (the day prior to the Merger), the closing price of one share of SouthState Common stock was $99.48.
    Remarks:
    On January 1, 2025, pursuant to the Agreement and Plan of Merger (the Merger Agreement), dated May 17, 2024, by and between Independent Bank Group, Inc. (Independent) and SouthState Corporation (SouthState), Independent merged with and into SouthState (the Merger).
    /s/ Mark Haynie, As Attorney in Fact 01/03/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $IBTX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IBTX

    DatePrice TargetRatingAnalyst
    5/31/2024$38.00 → $58.00Underweight → Overweight
    Piper Sandler
    4/24/2024$53.00 → $46.00Market Perform
    Hovde Group
    4/24/2024$48.00 → $38.00Neutral → Underweight
    Piper Sandler
    1/5/2024$56.00Mkt Perform → Outperform
    Raymond James
    7/26/2023$40.00 → $44.00Overweight → Neutral
    Piper Sandler
    10/26/2022$82.50 → $70.00Outperform → Market Perform
    Hovde Group
    3/9/2022Neutral
    Janney
    1/26/2022$80.00 → $85.00Buy
    Truist Securities
    More analyst ratings

    $IBTX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SouthState Closes Merger with Independent Financial

      Expands Presence in TX & CO and Adds Three Board Members WINTER HAVEN, Fla., Jan. 2, 2025 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState" or the "Company") today announced the closing of its acquisition of Independent Bank Group, Inc. (NASDAQ:IBTX) ("Independent Financial") on January 1, 2025, through the merger of Independent Financial with and into SouthState. Immediately after the merger, also on January 1, 2025, Independent Financial's subsidiary bank, Independent Bank, merged with and into SouthState Bank, N.A. ("SouthState Bank"). As a result of these transactions, the combined company has expanded its presence in Texas, entered Colorado, and increased its asset size to

      1/2/25 8:00:00 AM ET
      $IBTX
      $SSB
      Major Banks
      Finance
    • Acadia Pharmaceuticals Set to Join S&P SmallCap 600

      NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (NYSE:SSB) is acquiring Independent Bank Group in a deal expected to close soon pending final conditions. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Jan 3, 2025 S&P SmallCap 600 Addition Acadia Pharmaceuticals ACAD Health Care Jan 3, 2025 S&P SmallCap 600 Deletion Independent Bank Group

      12/30/24 5:37:00 PM ET
      $ACAD
      $IBTX
      $SPGI
      $SSB
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Major Banks
      Finance
    • Independent Bank Group, Inc. Reports Third Quarter Financial Results and Declares Quarterly Dividend

      Independent Bank Group, Inc. (NASDAQ:IBTX) today announced net income of $20.4 million, or $0.49 per diluted share, for the quarter ended September 30, 2024, compared to $32.8 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and net loss of $493,455 or ($11.93) per diluted share for the quarter ended June 30, 2024. Adjusted (non-GAAP) net income for the quarter ended September 30, 2024 was $20.6 million, or $0.50 per diluted share, compared to $32.6 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and $24.9 million, or $0.60 per diluted share for the quarter ended June 30, 2024. The Company also announced that its Board of Directors d

      10/21/24 5:00:00 PM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    SEC Filings

    See more
    • SEC Form 15-12G filed by Independent Bank Group Inc

      15-12G - Independent Bank Group, Inc. (0001564618) (Filer)

      1/13/25 5:11:51 PM ET
      $IBTX
      Major Banks
      Finance
    • SEC Form 15-12G filed by Independent Bank Group Inc

      15-12G - Independent Bank Group, Inc. (0001564618) (Filer)

      1/13/25 5:09:11 PM ET
      $IBTX
      Major Banks
      Finance
    • SEC Form 15-12G filed by Independent Bank Group Inc

      15-12G - Independent Bank Group, Inc. (0001564618) (Filer)

      1/13/25 5:08:34 PM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Independent Bank Group upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Independent Bank Group from Underweight to Overweight and set a new price target of $58.00 from $38.00 previously

      5/31/24 7:42:54 AM ET
      $IBTX
      Major Banks
      Finance
    • Hovde Group reiterated coverage on Independent Bank Group with a new price target

      Hovde Group reiterated coverage of Independent Bank Group with a rating of Market Perform and set a new price target of $46.00 from $53.00 previously

      4/24/24 6:41:00 AM ET
      $IBTX
      Major Banks
      Finance
    • Independent Bank Group downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Independent Bank Group from Neutral to Underweight and set a new price target of $38.00 from $48.00 previously

      4/24/24 6:16:27 AM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Independent Bank Group Inc (Amendment)

      SC 13G/A - Independent Bank Group, Inc. (0001564618) (Subject)

      2/13/24 5:06:20 PM ET
      $IBTX
      Major Banks
      Finance
    • SEC Form SC 13G/A filed by Independent Bank Group Inc (Amendment)

      SC 13G/A - Independent Bank Group, Inc. (0001564618) (Subject)

      2/9/24 5:46:33 PM ET
      $IBTX
      Major Banks
      Finance
    • SEC Form SC 13G/A filed by Independent Bank Group Inc (Amendment)

      SC 13G/A - Independent Bank Group, Inc. (0001564618) (Subject)

      2/9/24 9:16:05 AM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Viola Michael T returned 31,922 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Independent Bank Group, Inc. (0001564618) (Issuer)

      1/3/25 11:17:48 AM ET
      $IBTX
      Major Banks
      Finance
    • Director Washington Paul returned 5,029 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Independent Bank Group, Inc. (0001564618) (Issuer)

      1/3/25 11:16:30 AM ET
      $IBTX
      Major Banks
      Finance
    • Director Poarch Donald L returned 147,508 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Independent Bank Group, Inc. (0001564618) (Issuer)

      1/3/25 11:15:19 AM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    Financials

    Live finance-specific insights

    See more
    • SouthState Corporation to Acquire Texas-based Independent Bank Group, Inc.

      WINTER HAVEN, Fla. and MCKINNEY, Texas, May 20, 2024 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState") and Independent Bank Group, Inc. (NASDAQ:IBTX) ("Independent Bank Group") jointly announced today that they have entered into a definitive agreement under which SouthState will acquire Independent Bank Group, in an all-stock transaction valued at approximately $2 billion. Independent Bank Group, based in McKinney, Texas, has approximately $18.9 billion in total assets, $15.7 billion in total deposits and $14.6 billion in total loans as of March 31, 2024, and op

      5/20/24 7:00:00 AM ET
      $IBTX
      $SSB
      Major Banks
      Finance
    • Independent Bank Group, Inc. Reports First Quarter Financial Results and Declares Quarterly Dividend

      Independent Bank Group, Inc. (NASDAQ:IBTX) today announced net income of $24.2 million, or $0.58 per diluted share, for the quarter ended March 31, 2024, compared to $14.9 million, or $0.36 per diluted share for the quarter ended December 31, 2023. Adjusted (non-GAAP) net income for the quarter ended March 31, 2024 was $26.0 million, or $0.63 per diluted share, compared to $25.5 million, or $0.62 per diluted share for the quarter ended December 31, 2023. The Company also announced that its Board of Directors declared a quarterly cash dividend of $0.38 per share of common stock. The dividend will be payable on May 16, 2024 to stockholders of record as of the close of business on May 2, 202

      4/22/24 5:00:00 PM ET
      $IBTX
      Major Banks
      Finance
    • Independent Bank Group, Inc. Announces Date for Q1 2024 Earnings Call

      Independent Bank Group, Inc. (NASDAQ:IBTX), the holding company for Independent Financial, will hold a conference call to discuss first quarter 2024 results on Tuesday, April 23, 2024, at 8:30 am ET. The related press release will be issued Monday, April 22, 2024, after 4:00 pm ET. Conference Call Details The call can be accessed by the webcast link, https://www.webcast-eqs.com/indepbankgroupq12024_en/en, or by calling 1-877-407-0989 and by identifying the meeting number 13745780 or by identifying "Independent Bank Group First Quarter 2024 Earnings Conference Call". The conference materials will also be available by accessing the Investor Relations page of our website, www.ifinancial.co

      4/9/24 5:32:00 PM ET
      $IBTX
      Major Banks
      Finance

    $IBTX
    Leadership Updates

    Live Leadership Updates

    See more
    • SouthState Closes Merger with Independent Financial

      Expands Presence in TX & CO and Adds Three Board Members WINTER HAVEN, Fla., Jan. 2, 2025 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState" or the "Company") today announced the closing of its acquisition of Independent Bank Group, Inc. (NASDAQ:IBTX) ("Independent Financial") on January 1, 2025, through the merger of Independent Financial with and into SouthState. Immediately after the merger, also on January 1, 2025, Independent Financial's subsidiary bank, Independent Bank, merged with and into SouthState Bank, N.A. ("SouthState Bank"). As a result of these transactions, the combined company has expanded its presence in Texas, entered Colorado, and increased its asset size to

      1/2/25 8:00:00 AM ET
      $IBTX
      $SSB
      Major Banks
      Finance
    • Acadia Pharmaceuticals Set to Join S&P SmallCap 600

      NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (NYSE:SSB) is acquiring Independent Bank Group in a deal expected to close soon pending final conditions. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Jan 3, 2025 S&P SmallCap 600 Addition Acadia Pharmaceuticals ACAD Health Care Jan 3, 2025 S&P SmallCap 600 Deletion Independent Bank Group

      12/30/24 5:37:00 PM ET
      $ACAD
      $IBTX
      $SPGI
      $SSB
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Major Banks
      Finance
    • Independent Bank Group, Inc. Reports Third Quarter Financial Results and Declares Quarterly Dividend

      Independent Bank Group, Inc. (NASDAQ:IBTX) today announced net income of $20.4 million, or $0.49 per diluted share, for the quarter ended September 30, 2024, compared to $32.8 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and net loss of $493,455 or ($11.93) per diluted share for the quarter ended June 30, 2024. Adjusted (non-GAAP) net income for the quarter ended September 30, 2024 was $20.6 million, or $0.50 per diluted share, compared to $32.6 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and $24.9 million, or $0.60 per diluted share for the quarter ended June 30, 2024. The Company also announced that its Board of Directors d

      10/21/24 5:00:00 PM ET
      $IBTX
      Major Banks
      Finance